About SoviHep Tablets
Sovihep V 400mg/100mg Tablet is used in the treatment of chronic hepatitis C virus (HCV) infection.Sovihep V 400mg/100mg Tablet is a combination of two antiviral medicines Sofosbuvir and Velpatasvir. They work by lowering the amount of hepatitis C virus in the body and removing the virus from the blood over a period of time.
Potent Antiviral Therapy for HCVSoviHep Tablets are designed to target and inhibit the Hepatitis C Virus at the molecular level, providing a direct-acting antiviral solution for adults. Its active ingredient, Sofosbuvir 400 mg, interrupts virus replication, significantly improving treatment outcomes. SoviHep is part of comprehensive antiviral therapy regimens for chronic HCV infections, contributing to high sustained virologic response rates and the potential for cure.
Convenient and Safe Oral AdministrationThese tablets offer the ease of once-daily oral dosing, making adherence to treatment schedules more manageable. The film-coated tablets are both odorless and easy to swallow. For optimal results and patient safety, SoviHep should be consumed under close medical supervision, following your doctor's prescribed regimen.
Quality and Compliance AssuredManufactured by Zydus Healthcare Ltd. in India, SoviHep meets rigorous standards for pharmaceutical efficacy and safety. The packaging ensures product integrity, while storage recommendations-cool and dry conditions-help maintain shelf life and potency. Each bottle is clearly labelled and the tablets feature a unique 'SH' marking for easy identification.
FAQ's of SoviHep Tablets:
Q: How should SoviHep Tablets be taken for chronic HCV infection?
A: SoviHep Tablets are intended for oral administration and should be taken exactly as prescribed by your healthcare provider. The typical regimen involves swallowing one 400 mg tablet daily, with or without food. It's crucial to complete the full course as directed to achieve the best antiviral response.
Q: What is the main benefit of using SoviHep Tablets for Hepatitis C?
A: The primary benefit of SoviHep Tablets is their direct-acting antiviral activity, which aggressively targets and inhibits the Hepatitis C Virus. This results in higher chances of achieving a sustained virologic response, potentially leading to complete clearance of the virus from the body.
Q: When can adult patients expect to see improvement after starting SoviHep therapy?
A: Improvement timelines vary, but many patients begin to notice clinical and laboratory improvements within a few weeks of initiation. However, the duration of therapy often ranges from 12 to 24 weeks, and patients should undergo regular medical monitoring throughout the treatment.
Q: Where should SoviHep Tablets be stored to maintain their efficacy?
A: Store SoviHep Tablets in a cool, dry place, away from direct sunlight, heat, and moisture. Proper storage ensures that the medication remains effective for up to its 24-month shelf life.
Q: What precautions should be followed when using SoviHep Tablets?
A: SoviHep Tablets must be taken only under the supervision of a qualified healthcare professional. Do not adjust or discontinue your dosage without consulting your doctor, and always adhere to prescribed usage to minimize risks and maximize therapeutic benefit.
Q: What are the identifying features of SoviHep Tablets?
A: SoviHep Tablets are white to off-white, film-coated, and embossed with 'SH' on one side for easy recognition. They are odorless and come packaged in bottles containing 28 tablets.
Q: Who can prescribe SoviHep Tablets, and are they available over the counter?
A: SoviHep Tablets are a prescription-only medication and can only be prescribed by a licensed healthcare professional. They are not available for over-the-counter purchase in India and must be used under medical supervision.
Send Inquiry
